Pages that link to "Q39068511"

The following pages link to Advanced generation anti-prostate specific membrane antigen designer T cells for prostate cancer immunotherapy (Q39068511):

Displaying 18 items.

• PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models (Q27339832) (← links)
• Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases (Q35862775) (← links)
• Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer (Q35980893) (← links)
• Chimaeric antigen receptor T-cell therapy for tumour immunotherapy (Q37609801) (← links)
• Chimeric antigen receptor T cells: a novel therapy for solid tumors (Q37728639) (← links)
• Molecular insights into the development of T cell-based immunotherapy for prostate cancer (Q38254639) (← links)
• The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease (Q38831232) (← links)
• Enhancement of the T-cell armamentarium as a cell-based therapy for prostate cancer (Q42072059) (← links)
• Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response (Q45855437) (← links)
• CART cell therapy for prostate cancer: status and promise (Q60921911) (← links)
• Revisiting Immunotherapy: A Focus on Prostate Cancer (Q89746804) (← links)
• CAR-T cell therapy: a potential new strategy against prostate cancer (Q90751917) (← links)
• Targeting Cancer with Genetically Engineered TCR T Cells (Q93039761) (← links)
• Chimeric-Antigen-Receptor (CAR) T Cells and the Factors Influencing their Therapeutic Efficacy (Q93166160) (← links)
• PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model (Q98165142) (← links)
• Immunotherapy in prostate cancer: current state and future perspectives (Q99579001) (← links)
• Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options (Q100425524) (← links)
• Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies (Q101476445) (← links)